Fable Therapeutics is at the forefront of biologics development, utilizing advanced machine learning and protein engineering to revolutionize drug discovery. Their innovative platform integrates extensive datasets, including billions of protein sequences and structures, to create precision-engineered biologics. By employing a dual approach with both structure-based and sequence-based models, Fable can analyze proteins at the atomic level, identifying patterns that inform the design of novel therapeutics. This capability allows them to craft medicines that are specifically tailored to address complex biological challenges, enhancing therapeutic efficacy and safety.

The company's unique strategy focuses on overcoming traditional limitations in therapeutic development by harmonizing computational techniques with biological insights. Fable's machine learning infrastructure enables the rapid co-optimization of multiple parameters, ensuring that the designed proteins exhibit desirable characteristics such as binding affinity and developability. Their commitment to continuous data generation and integration of experimental findings further strengthens their position in the field, allowing them to deliver diverse, potent, and selective protein-based therapeutics that meet the evolving needs of medicine.

United States

Fable Therapeutics Inc. was founded with a conviction to revolutionize drug discovery through the purposeful integration of AI techniques.
‍
Our cross-functional team of ML scientists and drug hunters collaborate to design novel medicines with expanded therapeutic potential.
‍
With this passion and vision, we’re designing the future of drug discovery.

Fable Therapeutics

Company Details